| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-19388SS | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| IHC-Prediluted | NBP2-44806 | |||
| Azide and BSA Free | NBP2-34694-0.1mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-37330-0.025ml | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-54790SS | |||
| Azide and BSA Free | NBP2-80644 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-90364-25ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-33819-25ul | |||
![Western Blot: Erythropoietin R Antibody [NBP1-19388] - Western blot analysis of K562 (left) and SH-SY5Y (right) cell lysate using EPO receptor antibody at a concentration of 2 ug/ml.](http://images.novusbio.com/fullsize/Erythropoietin-R-Antibody-Western-Blot-NBP1-19388-img0004.jpg "Western Blot: Erythropoietin R Antibody [NBP1-19388] - Western blot analysis of K562 (left) and SH-SY5Y (right) cell lysate using EPO receptor antibody at a concentration of 2 ug/ml.")
![Immunocytochemistry/Immunofluorescence: Erythropoietin R Antibody [NBP1-19388] - EPO receptor antibody was tested in HeLa cells with DyLight 488 (green). Nuclei and alpha-tubulin were counterstained with DAPI (blue) and Dylight 550 (red).](http://images.novusbio.com/fullsize/Erythropoietin-R-Antibody-Immunocytochemistry-Immunofluorescence-NBP1-19388-img0003.jpg)
![Immunohistochemistry-Paraffin: Erythropoietin R Antibody [NBP1-19388] - IHC analysis of the EPO receptor in human placenta.](http://images.novusbio.com/fullsize/Erythropoietin-R-Antibody-Immunohistochemistry-Paraffin-NBP1-19388-img0002.jpg)
![Simple Western: Erythropoietin R Antibody [NBP1-19388] - Simple Western lane view shows a specific band for EPO Receptor in 0.5 mg/ml of Human Brain lysate. This experiment was performed under reducing conditions using the 12-230 kDa separation system.](http://images.novusbio.com/fullsize/Erythropoietin-R-Antibody-Simple-Western-NBP1-19388-img0005.jpg)
![Immunohistochemistry-Paraffin: RelA/NFkB p65 [p Ser276] Antibody [NB100-82086] - Immunohistochemical analysis of paraffin- embedded human lung carcinoma tissue using NB100-82086](http://images.novusbio.com/fullsize/RelA-NFkB-p65-[p-Ser276]-Antibody-Immunohistochemistry-Paraffin-NB100-82086-img0009.jpg "Immunohistochemistry-Paraffin: RelA/NFkB p65 [p Ser276] Antibody [NB100-82086] - Immunohistochemical analysis of paraffin- embedded human lung carcinoma tissue using NB100-82086")
![Immunocytochemistry/Immunofluorescence: RelA/NFkB p65 [p Ser276] Antibody [NB100-82086] - Staining of methanol-fixed Hela cells.](http://images.novusbio.com/fullsize/RelA-NFkB-p65-[p-Ser276]-Antibody-Immunocytochemistry-Immunofluorescence-NB100-82086-img0014.jpg)
![Immunohistochemistry-Paraffin: RelA/NFkB p65 [p Ser276] Antibody [NB100-82086] - Human breast carcinoma tissue.](http://images.novusbio.com/fullsize/RelA-NFkB-p65-[p-Ser276]-Antibody-Immunohistochemistry-Paraffin-NB100-82086-img0010.jpg)
![Western Blot: RelA/NFkB p65 [p Ser276] Antibody [NB100-82086] - Western Blot analysis of various cells using NB100-82086 diluted at 1:1000](http://images.novusbio.com/fullsize/nb100-82086_rabbit-polyclonal-rela-nfkb-p65-p-ser276-antibody-23420241545358.jpg)
![Immunohistochemistry-Paraffin: RelA/NFkB p65 [p Ser276] Antibody [NB100-82086] - Analysis of paraffin- embedded human breast carcinoma tissue using NB100-82086 incubated with blocking peptide (right)](http://images.novusbio.com/fullsize/nb100-82086_rabbit-polyclonal-rela-nfkb-p65-p-ser276-antibody-103202523464543.jpg)
![Immunocytochemistry/Immunofluorescence: RelA/NFkB p65 [p Ser276] Antibody [NB100-82086] - Immunofluorescence staining of methanol-fixed MEF cells untreated or treated with TNF using NB100-82086](http://images.novusbio.com/fullsize/nb100-82086_rabbit-polyclonal-rela-nfkb-p65-p-ser276-antibody-11320251555922.jpg)
![Western Blot: RelA/NFkB p65 [p Ser276] Antibody [NB100-82086] - Lane 1: HEK293. Lane 2: Lentivirus mediated NFkB overexpression. We image submitted by a verified customer review.](http://images.novusbio.com/fullsize/antibody/nb100-82086_rabbit-polyclonal-rela-nfkb-p65-p-ser276-antibody-western-blot-1132025204015..jpg)
![Immunohistochemistry-Paraffin: CD163 Antibody (K20-T) [NBP1-30148] - CD163 immunolabelling on a FFPE tissue section of human HCV liver biopsy. Image provided by Victoria Gadd.](http://images.novusbio.com/fullsize/CD163-Antibody-K20-T-Immunocytochemistry-Immunofluorescence-NBP1-30148-img0002.jpg "Immunohistochemistry-Paraffin: CD163 Antibody (K20-T) [NBP1-30148] - CD163 immunolabelling on a FFPE tissue section of human HCV liver biopsy. Image provided by Victoria Gadd.")
![Immunohistochemistry-Paraffin: CD163 Antibody (K20-T) [NBP1-30148] - CD163 expression in the macrophages of the bone marrow. FFPE human tissues (4 um sections) stained with anti-CD163.](http://images.novusbio.com/fullsize/CD163-Antibody-K20-T-Immunohistochemistry-Paraffin-NBP1-30148-img0006.jpg)
![Immunocytochemistry/Immunofluorescence: CD163 Antibody (K20-T) [NBP1-30148] - Human primary macrophages in 3D cell culture. Primary antibodies to CD163 (NBP1-30148; RED) and CD206 (clone 15-2; GREEN) were both diluted at 1:100 in blocking buffer and incubated overnight at 4C. This image represents a 100-micron Z-Stack displayed as maximum intensity projection. Image from verified customer review.](http://images.novusbio.com/fullsize/CD163-Antibody-K20-T-Immunocytochemistry-Immunofluorescence-NBP1-30148-img0010.jpg)
![Immunohistochemistry-Paraffin: CD163 Antibody (K20-T) [NBP1-30148] - Formalin fixed, paraffin embedded human tissues (4 um sections) stained with CD163 Antibody (K20-T).](http://images.novusbio.com/fullsize/CD163-Antibody-K20-T-Immunohistochemistry-Paraffin-NBP1-30148-img0011.jpg)
![Immunohistochemistry-Paraffin: CD163 Antibody (K20-T) [NBP1-30148] - Human bone marrow .](http://images.novusbio.com/fullsize/CD163-Antibody-K20-T-Immunohistochemistry-Paraffin-NBP1-30148-img0003.jpg)
![Immunohistochemistry-Paraffin: CD163 Antibody (K20-T) [NBP1-30148] - CD163-positive macrophages in the abscess of the liver. FFPE human tissues (4 um sections) stained with anti-CD163](http://images.novusbio.com/fullsize/CD163-Antibody-K20-T-Immunohistochemistry-Paraffin-NBP1-30148-img0008.jpg)
![Western Blot: Myelin PLP Antibody [NB100-74503] - Proteins were extracted from control (Ctrl) and stretched (Stretch) 158N cells and western blot was performed for myelin protein PLP (26 kDa) following 20% of strain. Beta-Actin was used as a loading control. Results represent the mean +/- SEM of three independent experiments. Image collected and cropped by CiteAb from the following publication (//www.ncbi.nlm.nih.gov/pmc/articles/PMC6505516/) licensed under a CC-BY license.](http://images.novusbio.com/fullsize/Myelin-PLP-Antibody-Western-Blot-NB100-74503-img0003.jpg "Western Blot: Myelin PLP Antibody [NB100-74503] - Proteins were extracted from control (Ctrl) and stretched (Stretch) 158N cells and western blot was performed for myelin protein PLP (26 kDa) following 20% of strain. Beta-Actin was used as a loading control. Results represent the mean +/- SEM of three independent experiments. Image collected and cropped by CiteAb from the following publication (//www.ncbi.nlm.nih.gov/pmc/articles/PMC6505516/) licensed under a CC-BY license.")
![Western Blot: Myelin PLP Antibody [NB100-74503] - Figure 1 shows a Western blot of PLP in adult mouse brain samples using NB100-74503. Figure 2 shows an immunocytochemical staining of PLP in mouse brain thick section using NB100-74503. Staining (m) is limited to myelin tracts and oligodendrocytes.](http://images.novusbio.com/fullsize/Myelin-PLP-Antibody-Western-Blot-NB100-74503-img0001.jpg)
![Western Blot: Myelin PLP Antibody [NB100-74503] - Analysis of adult mouse brain samples.](http://images.novusbio.com/fullsize/Myelin-PLP-Antibody-Western-Blot-NB100-74503-img0002.jpg)
![Western Blot: Myelin PLP Antibody [NB100-74503] - Alteration in myelin gene expression after in vitro mechanical tensile strain of 20% & 30%. Total RNA was extracted & RT-qPCR was performed in control (Ctrl) & stretched (Stretch) cells for myelin genes Mag (a, d), Cnp (b, e), & Plp (c, f, g, i) after strain of 20% (a, b, c, g) & 30% (d, e, f, i). Results represent the mean ± SEM of three independent experiments performed in triplicate. *p < 0.05; **p < 0.01. (h, j) Proteins were extracted from control (Ctrl) & stretched (Stretch) 158N cells & western blot was performed for myelin protein PLP (26 kDa) following 20% (h) & 30% (j) of strain. beta -Actin was used as a loading control. Results represent the mean ± SEM of three independent experiments Image collected & cropped by CiteAb from the following publication (//pubmed.ncbi.nlm.nih.gov/30298339), licensed under a CC-BY license. Not internally tested by Novus Biologicals.](http://images.novusbio.com/fullsize/nb100-74503_rabbit-polyclonal-myelin-plp-antibody-310202415392571.jpg)
![Western Blot: Myelin PLP Antibody [NB100-74503] - Alteration in myelin gene expression after in vitro mechanical tensile strain of 20% & 30%. Total RNA was extracted & RT-qPCR was performed in control (Ctrl) & stretched (Stretch) cells for myelin genes Mag (a, d), Cnp (b, e), & Plp (c, f, g, i) after strain of 20% (a, b, c, g) & 30% (d, e, f, i). Results represent the mean ± SEM of three independent experiments performed in triplicate. *p < 0.05; **p < 0.01. (h, j) Proteins were extracted from control (Ctrl) & stretched (Stretch) 158N cells & western blot was performed for myelin protein PLP (26 kDa) following 20% (h) & 30% (j) of strain. beta -Actin was used as a loading control. Results represent the mean ± SEM of three independent experiments Image collected & cropped by CiteAb from the following publication (//pubmed.ncbi.nlm.nih.gov/30298339), licensed under a CC-BY license. Not internally tested by Novus Biologicals.](http://images.novusbio.com/fullsize/nb100-74503_rabbit-polyclonal-myelin-plp-antibody-310202415334915.jpg)
![Western Blot: Myelin PLP Antibody [NB100-74503] - Mechanical tensile strain of 30% induces an elongation of paranodal junction & alteration in MAPK signaling in organotypic cerebellar slice culture. a Double immunostaining of organotypic cerebellar slices for CASPR in red & MAG in green. The response was evaluated at time 0 h post-stretch. Altered paranodal junctions are highlighted within white circles in high-magnification images. Scale bar, 50 μm; inset scale bar, 5 μm. b Sketch of CASPR & MAG labeling in the paranodal junction. Quantitative analysis is characterized by three length measurements: c nodal length called (A); d paranodal length called (B); & e (B-A) corresponding to the total length of the CASPR labeling. f–h Proteins were extracted following strain of 30% from control (Ctrl) & stretched (Stretch) slices & western blot was performed for the myelin protein MBP (f), ERK1/2 (g), & p38 (h). The ratio P-ERK on total ERK & the ratio P-p38 on total p38 are presented. beta -Actin was used as a loading control. Results represent the mean ± SEM (n = 3). ***p < 0.001. CASPR contactin-associated protein, MAG myelin-associated glycoprotein Image collected & cropped by CiteAb from the following publication (//pubmed.ncbi.nlm.nih.gov/30298339), licensed under a CC-BY license. Not internally tested by Novus Biologicals.](http://images.novusbio.com/fullsize/nb100-74503_rabbit-polyclonal-myelin-plp-antibody-3102024168216.jpg)
![Western Blot: Myelin PLP Antibody [NB100-74503] - Mechanical tensile strain of 30% induces an elongation of paranodal junction & alteration in MAPK signaling in organotypic cerebellar slice culture. a Double immunostaining of organotypic cerebellar slices for CASPR in red & MAG in green. The response was evaluated at time 0 h post-stretch. Altered paranodal junctions are highlighted within white circles in high-magnification images. Scale bar, 50 μm; inset scale bar, 5 μm. b Sketch of CASPR & MAG labeling in the paranodal junction. Quantitative analysis is characterized by three length measurements: c nodal length called (A); d paranodal length called (B); & e (B-A) corresponding to the total length of the CASPR labeling. f–h Proteins were extracted following strain of 30% from control (Ctrl) & stretched (Stretch) slices & western blot was performed for the myelin protein MBP (f), ERK1/2 (g), & p38 (h). The ratio P-ERK on total ERK & the ratio P-p38 on total p38 are presented. beta -Actin was used as a loading control. Results represent the mean ± SEM (n = 3). ***p < 0.001. CASPR contactin-associated protein, MAG myelin-associated glycoprotein Image collected & cropped by CiteAb from the following publication (//pubmed.ncbi.nlm.nih.gov/30298339), licensed under a CC-BY license. Not internally tested by Novus Biologicals.](http://images.novusbio.com/fullsize/nb100-74503_rabbit-polyclonal-myelin-plp-antibody-31020241555233.jpg)
![Western Blot: Myelin PLP Antibody [NB100-74503] - Mechanical tensile strain of 30% induces an elongation of paranodal junction & alteration in MAPK signaling in organotypic cerebellar slice culture. a Double immunostaining of organotypic cerebellar slices for CASPR in red & MAG in green. The response was evaluated at time 0 h post-stretch. Altered paranodal junctions are highlighted within white circles in high-magnification images. Scale bar, 50 μm; inset scale bar, 5 μm. b Sketch of CASPR & MAG labeling in the paranodal junction. Quantitative analysis is characterized by three length measurements: c nodal length called (A); d paranodal length called (B); & e (B-A) corresponding to the total length of the CASPR labeling. f–h Proteins were extracted following strain of 30% from control (Ctrl) & stretched (Stretch) slices & western blot was performed for the myelin protein MBP (f), ERK1/2 (g), & p38 (h). The ratio P-ERK on total ERK & the ratio P-p38 on total p38 are presented. beta -Actin was used as a loading control. Results represent the mean ± SEM (n = 3). ***p < 0.001. CASPR contactin-associated protein, MAG myelin-associated glycoprotein Image collected & cropped by CiteAb from the following publication (//pubmed.ncbi.nlm.nih.gov/30298339), licensed under a CC-BY license. Not internally tested by Novus Biologicals.](http://images.novusbio.com/fullsize/nb100-74503_rabbit-polyclonal-myelin-plp-antibody-3102024165743.jpg)
![Immunohistochemistry-Paraffin: CD63 Antibody (NKI/C3) [NBP2-32829] - Formalin-fixed, paraffin-embedded Mouse Spleen stained with (DAB Chromogen)](http://images.novusbio.com/fullsize/CD63-Antibody-NKI-C3-Immunohistochemistry-Paraffin-NBP2-32829-img0010.jpg "Immunohistochemistry-Paraffin: CD63 Antibody (NKI/C3) [NBP2-32829] - Formalin-fixed, paraffin-embedded Mouse Spleen stained with (DAB Chromogen)")
![Western Blot: CD63 Antibody (NKI/C3) [NBP2-32829] - Characterization of exosomes from HIV-infected T cells. CD63 and CD9 immunoblot (left) and AChE assays (right) of J1.1 exosomes isolated from 2, 10, and 20 ml of culture supernatants. Image collected and cropped by Citeab from the following publication (Exosomes derived from HIV-1-infected cells promote growth and progression of cancer via HIV TAR RNA. Nat Commun (2018) licensed under a CC-BY license.](http://images.novusbio.com/fullsize/CD63-Antibody-NKI-C3-Western-Blot-NBP2-32829-img0012.jpg)
![Western Blot: CD63 Antibody (NKI/C3) [NBP2-32829] - Characterization of exosomes from HIV-infected T cells. Immunoblot of CD63, CD9, and CD81 on proteins extracted from T-cell line exosomes (whole scans of blots in Supplementary Figure 1). Image collected and cropped by Citeab from the following publication (Exosomes derived from HIV-1-infected cells promote growth and progression of cancer via HIV TAR RNA. Nat Commun (2018) licensed under a CC-BY license.](http://images.novusbio.com/fullsize/CD63-Antibody-NKI-C3-Western-Blot-NBP2-32829-img0013.jpg)
![Flow Cytometry: CD63 Antibody (NKI/C3) [NBP2-32829] - Flow cytometry Analysis of live MCF-7 cells unstained (gray) or stained with biotin-labeled CD63 monoclonal antibody (NKI-C3) followed by streptavidin-CF568 (orange).](http://images.novusbio.com/fullsize/CD63-Antibody-NKI-C3-Flow-Cytometry-NBP2-32829-img0016.jpg)
![Immunohistochemistry-Paraffin: CD63 Antibody (NKI/C3) [NBP2-32829] - Formalin-fixed, paraffin-embedded human Melanoma stained with CD63 Antibody (NKI/C3) (AEC Chromogen)](http://images.novusbio.com/fullsize/CD63-Antibody-NKI-C3-Immunohistochemistry-Paraffin-NBP2-32829-img0009.jpg)
![Flow Cytometry: CD63 Antibody (NKI/C3) [NBP2-32829] - Human CD63 on MCF-7 cells. Black: Cells alone; Green: Isotype Control; Red: PE-labeled CD63 Monoclonal Antibody (NKI/C3).](http://images.novusbio.com/fullsize/CD63-Antibody-NKI-C3-Flow-Cytometry-NBP2-32829-img0005.jpg)
![Flow Cytometry: CD63 Antibody (NKI/C3) [NBP2-32829] - Flow Cytometric Analysis of U8G cells using PE-labeled CD63 Monoclonal Antibody (NKI/C3) Isotype Control (Red).](http://images.novusbio.com/fullsize/CD63-Antibody-NKI-C3-Flow-Cytometry-NBP2-32829-img0015.jpg)
![TIRAP (TLR2 and TLR4) Inhibitor Peptide [NBP2-26245] - TLR2 acts through formation of heterodimer complexes with TLR1 or TLR6. HEK 293 endogenously expresses TLR1 and TLR6, so that the TLR2 reporter cell line can response to both Pam3CSK4 (TLR2/TLR1 specific ligand) and MALP-2 (TLR2/TLR6 specific ligand). The TLR2 / TLR4 inhibitor specifically inhibits TLR2/TLR1 receptor complex activity in a dose-response manner but exhibited no or little effect on TLR2/TLR6 receptor complex activity.](http://images.novusbio.com/fullsize/TIRAP-TLR2-and-TLR4-Inhibitor-Peptide-NBP2-26245-img0007.jpg "TIRAP (TLR2 and TLR4) Inhibitor Peptide [NBP2-26245] - TLR2 acts through formation of heterodimer complexes with TLR1 or TLR6. HEK 293 endogenously expresses TLR1 and TLR6, so that the TLR2 reporter cell line can response to both Pam3CSK4 (TLR2/TLR1 specific ligand) and MALP-2 (TLR2/TLR6 specific ligand). The TLR2 / TLR4 inhibitor specifically inhibits TLR2/TLR1 receptor complex activity in a dose-response manner but exhibited no or little effect on TLR2/TLR6 receptor complex activity.")
![TIRAP (TLR2 and TLR4) Inhibitor Peptide [NBP2-26245] - The TLR4 reporter cell line responds to LPS. The TLR2 / TLR4 inhibitor specifically inhibits TLR4 activation upon LPS stimulation in a dose-response manner.](http://images.novusbio.com/fullsize/TIRAP-TLR2-and-TLR4-Inhibitor-Peptide-NBP2-26245-img0008.jpg)
![TIRAP (TLR2 and TLR4) Inhibitor Peptide [NBP2-26245] - TLR2 /4 Inhibitor suppressed the Pam3CSK4-induced TLR2/TLR1 activity [A] and the LPS-induced TLR4 activity [B] in a dose-response manner, of which IC50 values were measured as 17.2 uM and 10.47 uM, respectively.](http://images.novusbio.com/fullsize/TIRAP-TLR2-and-TLR4-Inhibitor-Peptide-NBP2-26245-img0009.jpg)
![Western Blot: CD90/Thy1 Antibody (7E1B11) [NBP2-37330] - Analysis using THY1 mouse mAb against T47D (1), HepG2 (2) and PC-12 (3) cell lysate.](http://images.novusbio.com/fullsize/CD90-Thy1-Antibody-7E1B11-Western-Blot-NBP2-37330-img0004.jpg "Western Blot: CD90/Thy1 Antibody (7E1B11) [NBP2-37330] - Analysis using THY1 mouse mAb against T47D (1), HepG2 (2) and PC-12 (3) cell lysate.")
![Immunocytochemistry/Immunofluorescence: CD90/Thy1 Antibody (7E1B11) - BSA Free [NBP2-37330] - CD90/Thy1 antibody (7E1B11) in indirect immunofluorescence staining of primary human fibroblasts using a red-fluorescent secondary antibody. Nuclei stained with DAPI (blue). Adjacent epithelial tumor cells stain negative for CD90. Image from verified customer review.](http://images.novusbio.com/fullsize/CD90-Thy1-Antibody-7E1B11-BSA-Free-Immunocytochemistry-Immunofluorescence-NBP2-37330-img0009.jpg)
![Immunohistochemistry-Paraffin: CD90/Thy1 Antibody (7E1B11) [NBP2-37330] - CD90 staining in human tonsil and aorta tissue. IHC-P image submitted by a verified customer review.](http://images.novusbio.com/fullsize/CD90-Thy1-Antibody-7E1B11-Immunohistochemistry-Paraffin-NBP2-37330-img0008.jpg)
![Western Blot: CD90/Thy1 Antibody (7E1B11) [NBP2-37330] - Analysis using THY1 mAb against human THY1 recombinant protein. (Expected MW is 38.5 kDa).](http://images.novusbio.com/fullsize/CD90-Thy1-Antibody-7E1B11-Western-Blot-NBP2-37330-img0002.jpg)
![Western Blot: CD90/Thy1 Antibody (7E1B11) [NBP2-37330] - Analysis using THY1 mAb against HEK293 (1) and THY1 (AA: 17-132)-hIgGFc transfected HEK293 (2) cell lysate.](http://images.novusbio.com/fullsize/CD90-Thy1-Antibody-7E1B11-Western-Blot-NBP2-37330-img0003.jpg)
![Immunocytochemistry/Immunofluorescence: CD90/Thy1 Antibody (7E1B11) [NBP2-37330] - Immunofluorescence analysis of Hela cells using THY1 mouse mAb (green). Blue: DRAQ5 fluorescent DNA dye. Red: Actin filaments have been labeled with Alexa Fluor-555 phalloidin.](http://images.novusbio.com/fullsize/CD90-Thy1-Antibody-7E1B11-Immunocytochemistry-Immunofluorescence-NBP2-37330-img0005.jpg)
![Immunohistochemistry-Paraffin: CD90/Thy1 Antibody (7E1B11) [NBP2-37330] - Analysis of endometrial cancer tissues using THY1 mouse mAb with DAB staining.](http://images.novusbio.com/fullsize/CD90-Thy1-Antibody-7E1B11-Immunohistochemistry-NBP2-37330-img0006.jpg)
![Immunohistochemistry-Paraffin: CD90/Thy1 Antibody (7E1B11) [NBP2-37330] - Analysis of cerebellum tissues using THY1 mouse mAb with DAB staining.](http://images.novusbio.com/fullsize/CD90-Thy1-Antibody-7E1B11-Immunohistochemistry-NBP2-37330-img0007.jpg)
![ELISA: CD90/Thy1 Antibody (7E1B11) [NBP2-37330] - Red: Control Antigen (100ng); Purple: Antigen (10ng); Green: Antigen (50ng); Blue: Antigen (100ng);](http://images.novusbio.com/fullsize/CD90-Thy1-Antibody-7E1B11-ELISA-NBP2-37330-img0001.jpg)
![Immunohistochemistry-Paraffin: DPPIV/CD26 Antibody - BSA Free [NB100-59021] - Immunohistochemical expression of DPPIV/CD26 in colorectal adenocarcinoma. DPPIV/CD26 immunostaining is located in the cytoplasm of adenomas and CRC cells displaying luminal membrane reinforcement. Image collected and cropped by CiteAb from the following publication (//dx.plos.org/10.1371/journal.pone.0119436), licensed under a CC-BY license.](http://images.novusbio.com/fullsize/DPPIV-CD26-Antibody---BSA-Free-Immunohistochemistry-Paraffin-NB100-59021-img0005.jpg "Immunohistochemistry-Paraffin: DPPIV/CD26 Antibody - BSA Free [NB100-59021] - Immunohistochemical expression of DPPIV/CD26 in colorectal adenocarcinoma. DPPIV/CD26 immunostaining is located in the cytoplasm of adenomas and CRC cells displaying luminal membrane reinforcement. Image collected and cropped by CiteAb from the following publication (//dx.plos.org/10.1371/journal.pone.0119436), licensed under a CC-BY license.")
![Immunohistochemistry-Paraffin: DPPIV/CD26 Antibody - BSA Free [NB100-59021] - Human Small Intestine: Formalin-Fixed, Paraffin-Embedded (FFPE)](http://images.novusbio.com/fullsize/DPPIV-CD26-Antibody---BSA-Free-Immunohistochemistry-Paraffin-NB100-59021-img0002.jpg)
![Immunohistochemistry-Paraffin: DPPIV/CD26 Antibody - BSA Free [NB100-59021] - Immunohistochemical expression of DPPIV/CD26 in normal colorectal mucosa. DPPIV/CD26 immunostaining is located in the cytoplasm of adenomas and CRC cells displaying luminal membrane reinforcement. Image collected and cropped by CiteAb from the following publication (//dx.plos.org/10.1371/journal.pone.0119436), licensed under a CC-BY license.](http://images.novusbio.com/fullsize/DPPIV-CD26-Antibody---BSA-Free-Immunohistochemistry-Paraffin-NB100-59021-img0003.jpg)
![Immunohistochemistry-Paraffin: DPPIV/CD26 Antibody - BSA Free [NB100-59021] - Immunohistochemical expression of DPPIV/CD26 in tubulovillous colonic adenoma. DPPIV/CD26 immunostaining is located in the cytoplasm of adenomas and CRC cells displaying luminal membrane reinforcement. Image collected and cropped by CiteAb from the following publication (//dx.plos.org/10.1371/journal.pone.0119436), licensed under a CC-BY license.](http://images.novusbio.com/fullsize/DPPIV-CD26-Antibody---BSA-Free-Immunohistochemistry-Paraffin-NB100-59021-img0004.jpg)
![Immunohistochemistry-Paraffin: DPPIV/CD26 Antibody - BSA Free [NB100-59021] - Immunohistochemical analysis of human prostate.](http://images.novusbio.com/fullsize/DPPIV-CD26-Antibody---BSA-Free-Immunohistochemistry-Paraffin-NB100-59021-img0006.jpg)
![Western Blot: CD36 Antibody (1283D) [NBP2-54790] - Western blot shows lysates of human placenta tissue and human platelets. PVDF membrane was probed with 1 ug/ml of Rabbit Anti-Human CD36 Monoclonal antibody (catalog number NBP2-54790) followed by HRP-conjugated Anti-Rabbit IgG Secondary Antibody (catalog number HAF008). A specific band was detected for CD36/SR-B3 at approximately 85 kDa (as indicated). This experiment was conducted under reducing conditions.](http://images.novusbio.com/fullsize/CD36-SR-B3-Antibody-1283D-Western-Blot-NBP2-54790-img0023.jpg "Western Blot: CD36 Antibody (1283D) [NBP2-54790] - Western blot shows lysates of human placenta tissue and human platelets. PVDF membrane was probed with 1 ug/ml of Rabbit Anti-Human CD36 Monoclonal antibody (catalog number NBP2-54790) followed by HRP-conjugated Anti-Rabbit IgG Secondary Antibody (catalog number HAF008). A specific band was detected for CD36/SR-B3 at approximately 85 kDa (as indicated). This experiment was conducted under reducing conditions.")
![Immunohistochemistry-Paraffin: CD36 Antibody (1283D) [NBP2-54790] - CD36 was detected in immersion fixed paraffin-embedded sections of human heart using Rabbit Anti-Human CD36/SR-B3 Monoclonal Antibody for 1 hour at room temperature followed by incubation with the Anti-Rabbit IgG VisUCyte(TM) HRP Polymer Antibody. Tissue was stained using DAB (brown) and counterstained with hematoxylin (blue). Specific staining was localized to cardiomyocyte membranes.](http://images.novusbio.com/fullsize/CD36-SR-B3-Antibody-1283D-Immunohistochemistry-Paraffin-NBP2-54790-img0002.jpg)
![Western Blot: CD36 Antibody (1283D) [NBP2-54790] - Total protein from human skin and adipose tissue was separated on a 12% gel by SDS-PAGE, transferred to PVDF membrane and blocked in 5% non-fat milk in TBST. The membrane was probed with 1.0 ug/ml anti-CD36 in 1% non-fat milk in TBST and detected with an anti-rabbit HRP secondary antibody using chemiluminescence.](http://images.novusbio.com/fullsize/CD36-SR-B3-Antibody-1283D-Western-Blot-NBP2-54790-img0001.jpg)
![Immunocytochemistry/Immunofluorescence: CD36 Antibody (1283D) [NBP2-54790] - HepG2 cells were fixed for 10 minutes using 10% formalin and then permeabilized for 5 minutes using 1X TBS + 0.5% Triton-X100. The cells were incubated with anti-CD36 (1283D) at 5.0 ug/ml overnight at 4C and detected with an anti-rabbit Dylight 488 (Green) at a 1:500 dilution. Alpha tubulin (DM1A) NB100-690 was used as a co-stain at a 1:1000 dilution and detected with an anti-mouse Dylight 550 (Red) at a 1:500 dilution. Nuclei were counterstained with DAPI (Blue). Cells were imaged using a 40X objective..](http://images.novusbio.com/fullsize/CD36-SR-B3-Antibody-1283D-Immunocytochemistry-Immunofluorescence-NBP2-54790-img0003.jpg)
![<b>Biological Strategies Validation. </b>Western Blot: CD36 Antibody (1283D) - BSA Free [NBP2-54790] - 3T3-L1 adipocytes were pretreated and treated with ML348 (10 uM) for 1 h, followed by BSA or oleate treatment for another 1 h. Image collected and cropped by CiteAb from the following publication (//pubmed.ncbi.nlm.nih.gov/32958780/) licensed under a CC-BY license.](http://images.novusbio.com/fullsize/CD36-Antibody-1283D-BSA-Free-Western-Blot-NBP2-54790-img0024.jpg)
![Western Blot: CD36 Antibody (1283D) - BSA Free [NBP2-54790] - LYN phosphorylates DHHC5 & is required for the endocytosis of FAs.a 3T3-L1 adipocytes pretreated with serum-free medium for 4 h & PP2 (15 μM) for 1 h, followed by treatment with BSA or oleate (100 μM) for 5 min. Cells harvested & immunoprecipitated with anti-DHHC5 antibody to detect phosphorylation of Tyr91. b 3T3-L1 adipocytes transduced with indicated shRNA set up & treated with oleate for 5 min. Cells harvested to detect Tyr91 phosphorylation as in (a). c On day 0, HEK293T cells set up at 2.5 × 105 cells per 6-cm dish. On day 2, cells transfected with 0.5 μg of WT, Y91E, or Y91F of DHHC5-Flag/pCDH-puro and/or 0.5 μg LYN/pCDNA3.3. On day 3, cells harvested & immunoprecipitated with anti-Flag M2 beads to detect phosphorylation of DHHC5 (pY). Control & LYN knockdown adipocytes pretreated & treated with BSA or oleate (100 μM) for 1 h, followed by immunostaining (d), surface biotinylation (e), & Acyl-RAC (f) assays. Control & CD36 knockdown 3T3-L1 adipocytes pretreated & treated with oleate (100 μM) for indicated time (g) or 5 min (h). Cells harvested & subjected to immunoprecipitation of LYN to detect phosphorylation of LYN (Y396). i, j WT & Cd36−/− SVFs set up & subjected to FA uptake as in Fig. 3h, i, except that cells pretreated with PP2 (15 μM). Each value represents mean ± SEM obtained from 20 cells. Two-sided Student’s t test was performed between DMSO & PP2 treated cells. k WT & Cd36−/− adipocytes set up & subjected to 3H-oleate uptake as in Fig. 3j, except that cells pretreated with PP2 (15 μM). Each value represents mean ± SEM obtained from 3samples. Two-sided Student’s t test was performed between DMSO & PP2 treated cells. These experiments repeated at least twice. Source data provided as a Source Data file. Image collected & cropped by CiteAb from the following publication (//pubmed.ncbi.nlm.nih.gov/32958780), licensed under a CC-BY license. Not internally tested by Novus Biologicals.](http://images.novusbio.com/fullsize/nbp2-54790_rabbit-monoclonal-cd36-antibody-1283d-3102024161365.jpg)
![Western Blot: CD36 Antibody (1283D) - BSA Free [NBP2-54790] - LYN phosphorylates DHHC5 & is required for the endocytosis of FAs.a 3T3-L1 adipocytes pretreated with serum-free medium for 4 h & PP2 (15 μM) for 1 h, followed by treatment with BSA or oleate (100 μM) for 5 min. Cells harvested & immunoprecipitated with anti-DHHC5 antibody to detect phosphorylation of Tyr91. b 3T3-L1 adipocytes transduced with indicated shRNA set up & treated with oleate for 5 min. Cells harvested to detect Tyr91 phosphorylation as in (a). c On day 0, HEK293T cells set up at 2.5 × 105 cells per 6-cm dish. On day 2, cells transfected with 0.5 μg of WT, Y91E, or Y91F of DHHC5-Flag/pCDH-puro and/or 0.5 μg LYN/pCDNA3.3. On day 3, cells harvested & immunoprecipitated with anti-Flag M2 beads to detect phosphorylation of DHHC5 (pY). Control & LYN knockdown adipocytes pretreated & treated with BSA or oleate (100 μM) for 1 h, followed by immunostaining (d), surface biotinylation (e), & Acyl-RAC (f) assays. Control & CD36 knockdown 3T3-L1 adipocytes pretreated & treated with oleate (100 μM) for indicated time (g) or 5 min (h). Cells harvested & subjected to immunoprecipitation of LYN to detect phosphorylation of LYN (Y396). i, j WT & Cd36−/− SVFs set up & subjected to FA uptake as in Fig. 3h, i, except that cells pretreated with PP2 (15 μM). Each value represents mean ± SEM obtained from 20 cells. Two-sided Student’s t test was performed between DMSO & PP2 treated cells. k WT & Cd36−/− adipocytes set up & subjected to 3H-oleate uptake as in Fig. 3j, except that cells pretreated with PP2 (15 μM). Each value represents mean ± SEM obtained from 3samples. Two-sided Student’s t test was performed between DMSO & PP2 treated cells. These experiments repeated at least twice. Source data provided as a Source Data file. Image collected & cropped by CiteAb from the following publication (//pubmed.ncbi.nlm.nih.gov/32958780), licensed under a CC-BY license. Not internally tested by Novus Biologicals.](http://images.novusbio.com/fullsize/nbp2-54790_rabbit-monoclonal-cd36-antibody-1283d-310202416114783.jpg)
![Western Blot: CD36 Antibody (1283D) - BSA Free [NBP2-54790] - FAs trigger internalization of CD36.a, b On day 8 of differentiation, 3T3-L1 adipocytes were pretreated with serum-free medium for 4 h, & then treated with BSA-conjugated oleate (100 μM) for indicated time. a One set of cells was subjected to immunostaining with anti-CD36 & anti-CAV1 antibodies. LipidTOX was used to label lipid droplets. Images were taken under a Zeiss LSM-780 microscope in a 3D Z-stack mode & reconstructed using Imaris 9.2.0. b The other set of cells was subjected to surface biotinylation assay & blotted with indicated antibodies. c, d On day 4 of differentiation, 3T3-L1 cells were infected with lentivirus encoding scrambled shRNA or shRNAs against CD36 or CAV1. On day 5, cells were selected with 5 μg/ml puromycin. On day 8, cells were pretreated as in (a) & treated with oleate (100 μM) for 4 h, followed by immunostaining with anti-CD36 & anti-CAV1 antibodies (c), or surface biotinylation assay (d). e, f 3T3-L1 adipocytes were pretreated as in (a) & treated with BSA-conjugated FAs with different chain lengths or saturation (100 μM) for 4 h. Cells were subjected to immunostaining with anti-CD36 antibody (e), or surface biotinylation assay (f). After oleate treatment for 4 h, 3T3-L1 adipocytes were switched to serum-free medium for indicated time & harvested for immunostaining (g) & surface biotinylation (h). The scale bars were as indicated in each figure. These experiments were repeated at least three times. Source data are provided as a Source Data file. Image collected & cropped by CiteAb from the following publication (//pubmed.ncbi.nlm.nih.gov/32958780), licensed under a CC-BY license. Not internally tested by Novus Biologicals.](http://images.novusbio.com/fullsize/nbp2-54790_rabbit-monoclonal-cd36-antibody-1283d-310202416121990.jpg)
![Western Blot: CD36 Antibody (1283D) - BSA Free [NBP2-54790] - FAs trigger internalization of CD36.a, b On day 8 of differentiation, 3T3-L1 adipocytes were pretreated with serum-free medium for 4 h, & then treated with BSA-conjugated oleate (100 μM) for indicated time. a One set of cells was subjected to immunostaining with anti-CD36 & anti-CAV1 antibodies. LipidTOX was used to label lipid droplets. Images were taken under a Zeiss LSM-780 microscope in a 3D Z-stack mode & reconstructed using Imaris 9.2.0. b The other set of cells was subjected to surface biotinylation assay & blotted with indicated antibodies. c, d On day 4 of differentiation, 3T3-L1 cells were infected with lentivirus encoding scrambled shRNA or shRNAs against CD36 or CAV1. On day 5, cells were selected with 5 μg/ml puromycin. On day 8, cells were pretreated as in (a) & treated with oleate (100 μM) for 4 h, followed by immunostaining with anti-CD36 & anti-CAV1 antibodies (c), or surface biotinylation assay (d). e, f 3T3-L1 adipocytes were pretreated as in (a) & treated with BSA-conjugated FAs with different chain lengths or saturation (100 μM) for 4 h. Cells were subjected to immunostaining with anti-CD36 antibody (e), or surface biotinylation assay (f). After oleate treatment for 4 h, 3T3-L1 adipocytes were switched to serum-free medium for indicated time & harvested for immunostaining (g) & surface biotinylation (h). The scale bars were as indicated in each figure. These experiments were repeated at least three times. Source data are provided as a Source Data file. Image collected & cropped by CiteAb from the following publication (//pubmed.ncbi.nlm.nih.gov/32958780), licensed under a CC-BY license. Not internally tested by Novus Biologicals.](http://images.novusbio.com/fullsize/nbp2-54790_rabbit-monoclonal-cd36-antibody-1283d-31020241612242.jpg)
![Western Blot: CD36 Antibody (1283D) - BSA Free [NBP2-54790] - FAs trigger internalization of CD36.a, b On day 8 of differentiation, 3T3-L1 adipocytes were pretreated with serum-free medium for 4 h, & then treated with BSA-conjugated oleate (100 μM) for indicated time. a One set of cells was subjected to immunostaining with anti-CD36 & anti-CAV1 antibodies. LipidTOX was used to label lipid droplets. Images were taken under a Zeiss LSM-780 microscope in a 3D Z-stack mode & reconstructed using Imaris 9.2.0. b The other set of cells was subjected to surface biotinylation assay & blotted with indicated antibodies. c, d On day 4 of differentiation, 3T3-L1 cells were infected with lentivirus encoding scrambled shRNA or shRNAs against CD36 or CAV1. On day 5, cells were selected with 5 μg/ml puromycin. On day 8, cells were pretreated as in (a) & treated with oleate (100 μM) for 4 h, followed by immunostaining with anti-CD36 & anti-CAV1 antibodies (c), or surface biotinylation assay (d). e, f 3T3-L1 adipocytes were pretreated as in (a) & treated with BSA-conjugated FAs with different chain lengths or saturation (100 μM) for 4 h. Cells were subjected to immunostaining with anti-CD36 antibody (e), or surface biotinylation assay (f). After oleate treatment for 4 h, 3T3-L1 adipocytes were switched to serum-free medium for indicated time & harvested for immunostaining (g) & surface biotinylation (h). The scale bars were as indicated in each figure. These experiments were repeated at least three times. Source data are provided as a Source Data file. Image collected & cropped by CiteAb from the following publication (//pubmed.ncbi.nlm.nih.gov/32958780), licensed under a CC-BY license. Not internally tested by Novus Biologicals.](http://images.novusbio.com/fullsize/nbp2-54790_rabbit-monoclonal-cd36-antibody-1283d-310202416114740.jpg)
![Western Blot: CD36 Antibody (1283D) - BSA Free [NBP2-54790] - FAs trigger internalization of CD36.a, b On day 8 of differentiation, 3T3-L1 adipocytes were pretreated with serum-free medium for 4 h, & then treated with BSA-conjugated oleate (100 μM) for indicated time. a One set of cells was subjected to immunostaining with anti-CD36 & anti-CAV1 antibodies. LipidTOX was used to label lipid droplets. Images were taken under a Zeiss LSM-780 microscope in a 3D Z-stack mode & reconstructed using Imaris 9.2.0. b The other set of cells was subjected to surface biotinylation assay & blotted with indicated antibodies. c, d On day 4 of differentiation, 3T3-L1 cells were infected with lentivirus encoding scrambled shRNA or shRNAs against CD36 or CAV1. On day 5, cells were selected with 5 μg/ml puromycin. On day 8, cells were pretreated as in (a) & treated with oleate (100 μM) for 4 h, followed by immunostaining with anti-CD36 & anti-CAV1 antibodies (c), or surface biotinylation assay (d). e, f 3T3-L1 adipocytes were pretreated as in (a) & treated with BSA-conjugated FAs with different chain lengths or saturation (100 μM) for 4 h. Cells were subjected to immunostaining with anti-CD36 antibody (e), or surface biotinylation assay (f). After oleate treatment for 4 h, 3T3-L1 adipocytes were switched to serum-free medium for indicated time & harvested for immunostaining (g) & surface biotinylation (h). The scale bars were as indicated in each figure. These experiments were repeated at least three times. Source data are provided as a Source Data file. Image collected & cropped by CiteAb from the following publication (//pubmed.ncbi.nlm.nih.gov/32958780), licensed under a CC-BY license. Not internally tested by Novus Biologicals.](http://images.novusbio.com/fullsize/nbp2-54790_rabbit-monoclonal-cd36-antibody-1283d-310202416114741.jpg)
![Western Blot: CD36 Antibody (1283D) - BSA Free [NBP2-54790] - CD36-mediated caveolar endocytosis transports FAs into cells.a–c 3T3-L1 adipocytes were pretreated with serum-free medium for 4 h, & then treated with BSA-conjugated PacFA (50 μM) for 20 min, followed by UV crosslinking on ice for 30 min. a, b Cells were subjected to click chemistry using an N3-Alexa Fluro 488, & immunostained with anti-CD36 antibody. Colocalization of PacFA & CD36 was quantified from 24 cells over three independent experiments & plotted in (b). The value represents mean ± SEM. c Cells were lysed & subjected to click chemistry assay using N3-biotin. PacFA-labeled proteins were captured with streptavidin beads & subjected to western blot using anti-CD36 & anti-FABP4 antibodies. d WT, Cav1−/−, Cd36−/−, & Cav1−/−;Cd36−/− SVFs were isolated & differentiated into adipocytes & treated with 100 μM 3H-oleate (specific activity, 2268 dpm/nmol) for 1 h. Lipid fractions were extracted from the cells & subjected to scintillation counting. The radioactive counting was normalized to protein content. Each value represents mean ± SEM obtained from three samples. Two-sided Student’s t test was performed between WT & each of the knockout cells. These experiments were repeated twice. Source data are provided as a Source Data file. Image collected & cropped by CiteAb from the following publication (//pubmed.ncbi.nlm.nih.gov/32958780), licensed under a CC-BY license. Not internally tested by Novus Biologicals.](http://images.novusbio.com/fullsize/nbp2-54790_rabbit-monoclonal-cd36-antibody-1283d-310202416113520.jpg)
![Immunohistochemistry-Paraffin: CREB Antibody [NBP1-90364] - Staining of human small intestine shows strong nuclear positivity in glandular cells.](http://images.novusbio.com/fullsize/CREB-Antibody-Immunohistochemistry-Paraffin-NBP1-90364-img0002.jpg)
![Lane 1: Marker [kDa] 230, 130, 95, 72, 56, 36, 28, 17, 11Lane 2: Human cell line RT-4Lane 3: Human cell line U-251MG sp](http://images.novusbio.com/fullsize/nbp1-90364_rabbit-polyclonal-creb-antibody-3052025726383.jpg)
![Simple Western: CREB Antibody [NBP1-90364] - Human foreskin cell lysate. CREB antibody dilution of 1:50. Protein concentration is 750 ug/mL. Detection is chemiluminescence. Simple Western image submitted by a verified customer review.](http://images.novusbio.com/fullsize/CREB-Antibody-Simple-Western-NBP1-90364-img0008.jpg)
![Simple Western: CREB Antibody [NBP1-90364] - Detection of CREB by Simple Western (JESS) in reconstructed human epidermis lysate (about 600 ug/mL protein concentration). Antibody at 1:50. Simple Western image submitted by a verified customer review.](http://images.novusbio.com/fullsize/CREB-Antibody-Simple-Western-NBP1-90364-img0009.jpg)
![Western Blot: CXCL8/IL-8 Antibody [NBP2-33819] - Analysis in human cell line EFO-21.](http://images.novusbio.com/fullsize/CXCL8-IL-8-Antibody-Western-Blot-NBP2-33819-img0005.jpg "Western Blot: CXCL8/IL-8 Antibody [NBP2-33819] - Analysis in human cell line EFO-21.")
![Immunocytochemistry/Immunofluorescence: CXCL8/IL-8 Antibody [NBP2-33819] - Staining of human cell line U-251 MG shows localization to the Golgi apparatus. Antibody staining is shown in green.](http://images.novusbio.com/fullsize/CXCL8-IL-8-Antibody-Immunocytochemistry-Immunofluorescence-NBP2-33819-img0006.jpg)
![Immunohistochemistry-Paraffin: CXCL8/IL-8 Antibody [NBP2-33819] - Staining of human rectum shows moderate positivity in plasma.](http://images.novusbio.com/fullsize/CXCL8-IL-8-Antibody-Immunohistochemistry-Paraffin-NBP2-33819-img0010.jpg)
![Immunohistochemistry-Paraffin: CXCL8/IL-8 Antibody [NBP2-33819] - Staining of human fallopian tube shows no positivity in glandular cells as expected.](http://images.novusbio.com/fullsize/CXCL8-IL-8-Antibody-Immunohistochemistry-Paraffin-NBP2-33819-img0007.jpg)
![Immunohistochemistry-Paraffin: CXCL8/IL-8 Antibody [NBP2-33819] - Staining of human lymph node shows weak to moderate cytoplasmic positivity in a subset of non-germinal center cells.](http://images.novusbio.com/fullsize/CXCL8-IL-8-Antibody-Immunohistochemistry-Paraffin-NBP2-33819-img0008.jpg)
![Immunohistochemistry-Paraffin: CXCL8/IL-8 Antibody [NBP2-33819] - Staining of human placenta shows moderate positivity in plasma.](http://images.novusbio.com/fullsize/CXCL8-IL-8-Antibody-Immunohistochemistry-Paraffin-NBP2-33819-img0009.jpg)
![Western Blot: IRF6 Antibody [NBP1-51911] - HEK293 overexpressing IRF6 and probed with (mock transfection in first lane).](http://images.novusbio.com/fullsize/IRF6-Antibody-Western-Blot-NBP1-51911-img0003.jpg "Western Blot: IRF6 Antibody [NBP1-51911] - HEK293 overexpressing IRF6 and probed with (mock transfection in first lane).")
![Immunohistochemistry-Paraffin: IRF6 Antibody [NBP1-51911] - Staining of paraffin embedded Human Kidney. Steamed antigen retrieval with citrate buffer pH 6, AP-staining.](http://images.novusbio.com/fullsize/IRF6-Antibody-Immunohistochemistry-Paraffin-NBP1-51911-img0006.jpg)
![Western Blot: IRF6 Antibody [NBP1-51911] - (0.2ug/ml) of Human Ovary lysate (RIPA buffer, 35ug total protein per lane). Primary incubated for 1 hour. Detected by western blot using chemiluminescence.](http://images.novusbio.com/fullsize/IRF6-Antibody-Western-Blot-NBP1-51911-img0001.jpg)
![Immunohistochemistry-Paraffin: IRF6 Antibody [NBP1-51911] - staining of paraffin embedded Human Prostate. Steamed antigen retrieval with citrate buffer pH 6, AP-staining.](http://images.novusbio.com/fullsize/IRF6-Antibody-Immunohistochemistry-Paraffin-NBP1-51911-img0004.jpg)
